Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: TOward a Better Understanding of the autoPhagy Machinery for the Identification of Potential Novel Biomarkers and Therapeutic Targets in Crohn's Disease - TOPIC Study [NA]
Describes the TOPIC study, a clinical trial aimed at understanding autophagy machinery to identify novel biomarkers and therapeutic targets …
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: Prebiotics and Diet to Reduce "Leaky" Gut in First Degree Relatives of Crohn's Disease Patients [NA]
Completed clinical trial assessing whether prebiotics and dietary changes can reduce gut permeability in healthy first-degree relatives of C…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Inflammatory Bowel Diseases Remission Registry
A registry study update for the Inflammatory Bowel Diseases Remission Registry, currently recruiting to collect data on Crohn's disease, ulc…
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease [Phase 4]
A phase 4 clinical trial update exploring therapeutic drug monitoring-based infliximab treatment for active perianal fistulizing Crohn's dis…
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD [NA]
This clinical trial update outlines a study evaluating switching between subcutaneous and intravenous infliximab in Crohn's disease patients…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: MRE Predictors of Disease Relapse After Stopping Biologics
A recruiting study from University College London investigates MRE-based predictors of relapse in Crohn's disease after stopping biologic th…
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: A Study Using Artificial Intelligence to Identify Adults With Complex Perianal Fistulas Associated With Crohn's Disease
Takeda-sponsored clinical trial used artificial intelligence to identify adults with complex perianal fistulas associated with Crohn's disea…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Non-invasive Assessment of RECTUM (POUCH) by US (RECT-US) in a Cohort of IBD Patients
A United States-based clinical trial is evaluating a non-invasive RECTUM assessment (RECT-US) in a cohort of inflammatory bowel disease pati…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Diet Patterns in IBD in Central Texas
A University of Texas at Austin clinical trial on diet patterns in inflammatory bowel diseases has been suspended, including Crohn's disease…
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease
A completed prospective evaluation of a scoring system for patients newly diagnosed with Crohn's disease, sponsored by Ferring Pharmaceutica…
-
FDA approval · 2024-04-30FDA Approved: ABRILADA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for ABRILADA (adalimumab-afzb) from Pfizer Laboratories Div Pfizer Inc, authorizing its use as a…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Effect of Probiotic Administration on Patients With Inflammatory Bowel Disease [NA]
A clinical trial is recruiting to evaluate the effect of probiotic administration on patients with inflammatory bowel disease, including ulc…
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Fertility and Pregnancy After Surgery IBD Audit
Recruiting clinical trial from the University of Campania Luigi Vanvitelli to study fertility and pregnancy outcomes after surgery in indivi…
-
FDA approval · 2024-04-18FDA Approved: ENTYVIO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Entyvio (vedolizumab) from Takeda Pharmaceuticals America, Inc., to modify labeling and expa…
-
FDA approval · 2024-04-18FDA Approved: ENTYVIO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Entyvio (vedolizumab) from Takeda Pharmaceuticals America, resulting in a labeling update fo…
-
CLINICAL_TRIALS withdrawal · 2024-04-18Clinical Trial Update: SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery [Phase 3]
A Phase 3 trial assessing aspirin versus standard of care for VTE prophylaxis after IBD surgery has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: A Phase 2a Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol as a Steroid-sparing Therapy in Steroid-dependent Crohn's Disease Patients [Phase 2]
Phase 2a study evaluating cannabidiol as a steroid-sparing therapy in steroid-dependent Crohn's disease has completed.
-
FDA approval · 2024-04-16FDA Approved: SELARSDI — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved SELARSDI (USTEKINUMAB-AEKN) from Teva Pharmaceuticals USA, Inc. under an original Biologics License Application (BLA 761343).
-
FDA approval · 2024-04-12FDA Approved: MESALAMINE — Supplemental Application (Encube Ethicals, Inc.)
FDA approved a supplemental application for Mesalamine from Encube Ethicals, Inc.
-
FDA approval · 2024-04-04FDA Approved: MESALAMINE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Mesalamine submitted by Ascend Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice
A real-life practice study evaluating disease control and treatment patterns in moderate to severe inflammatory bowel disease, completed wit…
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: Is Local Injection of Mesenchymal Stem Cells After Endoscopic Dilation Safe and Does it Improve the Outcome of Intestinal Stricture in Patients With Crohn's Disease? [Phase 2]
Phase 2 clinical trial investigating local injection of mesenchymal stem cells after endoscopic dilation for Crohn's disease-related intesti…
-
FDA approval · 2024-03-18FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for ustekinumab submitted by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical Outcomes
A completed clinical trial evaluating the relationship between vedolizumab therapeutic drug monitoring, inflammation biomarkers, and clinica…
-
FDA approval · 2024-03-14FDA Approved: ENTYVIO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ENTYVIO (vedolizumab) submitted by Takeda Pharmaceuticals America, Inc. The action updates the p…